Correlation Between CENTURIA OFFICE and BB Biotech

Can any of the company-specific risk be diversified away by investing in both CENTURIA OFFICE and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CENTURIA OFFICE and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CENTURIA OFFICE REIT and BB Biotech AG, you can compare the effects of market volatilities on CENTURIA OFFICE and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CENTURIA OFFICE with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CENTURIA OFFICE and BB Biotech.

Diversification Opportunities for CENTURIA OFFICE and BB Biotech

0.55

Correlation Coefficient

CENTURIA OFFICE  BB Biotech

Very weak diversification

The 3 months correlation between CENTURIA and BBZA is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding CENTURIA OFFICE REIT and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and CENTURIA OFFICE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CENTURIA OFFICE REIT are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of CENTURIA OFFICE i.e., CENTURIA OFFICE and BB Biotech go up and down completely randomly.

Pair Corralation between CENTURIA OFFICE and BB Biotech

Assuming the 90 days horizon CENTURIA OFFICE REIT is expected to generate 1.61 times more return on investment than BB Biotech. However, CENTURIA OFFICE is 1.61 times more volatile than BB Biotech AG. It trades about 0.05 of its potential returns per unit of risk. BB Biotech AG is currently generating about -0.08 per unit of risk. If you would invest  61.00  in CENTURIA OFFICE REIT on December 23, 2024 and sell it today you would earn a total of  3.00  from holding CENTURIA OFFICE REIT or generate 4.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

CENTURIA OFFICE REIT  vs.  BB Biotech AG

CENTURIA OFFICE REIT

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CENTURIA OFFICE REIT are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, CENTURIA OFFICE is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

BB Biotech AG

Risk-Adjusted Performance

Very Weak

Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BB Biotech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with CENTURIA OFFICE and BB Biotech

The main advantage of trading using opposite CENTURIA OFFICE and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CENTURIA OFFICE position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.

The idea behind CENTURIA OFFICE REIT and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.